middle.news
Recce’s gel reaches a key Phase 3 test after encouraging blinded data
11:19am on Tuesday 20th of October, 2026 AEDT
•
Healthcare
Read Story
Recce’s gel reaches a key Phase 3 test after encouraging blinded data
11:19am on Tuesday 20th of October, 2026 AEDT
Key Points
Strong efficacy indicated in blinded review of 75 patients
Independent DMC to assess treatment-group data in mid-November
90 patients enrolled in the Indonesian Phase 3 trial
Recruitment continues at 4.5 patients per week
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Recce Pharmaceuticals (ASX:RCE)
OPEN ARTICLE